argus

Thyrocare Technologies Limited

NSE: THYROCAREINE594H010199,446 Cr

Timeline

Time (IST)TypeMEventSrc
07 May, 08:17 pmThyrocare Technologies Limited has informed the Exchange about equity infusion in Think Health Diagnostics Private Limited, wholly owned subsidiary of the Companynse
07 May, 08:13 pmThyrocare Technologies Limited has informed the Exchange regarding amendments to the Memorandum of Association of the Company.nse
07 May, 08:08 pmThyrocare Technologies Limited has informed the Exchange regarding Change in Auditors of the company.nse
07 May, 08:05 pmThyrocare Technologies Limited has informed the Exchange regarding Change in Director(s) of the company.nse
07 May, 08:03 pmThyrocare Technologies Limited has informed the Exchange regarding Resignation of Dharmil Nirupam Sheth and Dhaval Rajesh Shah as Non- Executive Directors of the company w.e.f. closure of business hours of May 07, 2026nse
07 May, 08:00 pmThyrocare Technologies Limited has informed the Exchange regarding Re-appointment of Mr. Rahul Franklin Guha as Managing Director & CEO of the company w.e.f. May 04, 2027.nse
07 May, 07:57 pmThyrocare Technologies Limited has informed the Exchange regarding Appointment of Mr. Uday Patel Kadam and Mr. Gaurav Verma as Non- Executive Director of the company w.e.f. May 08, 2026.nse
07 May, 07:53 pmThyrocare Technologies Limited has informed the Exchange regarding change in Directors of the Company.nse
07 May, 07:50 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Associationbse
07 May, 07:48 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Acquisitionbse
07 May, 07:46 pmThyrocare Technologies Ltd - 539871 - Appointment Of Cost Auditors For The Financial Year 2026-27bse
07 May, 07:44 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sbse
07 May, 07:42 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
07 May, 07:41 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Change in Managementbse
07 May, 07:39 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
07 May, 07:34 pmThyrocare Technologies Ltd - 539871 - Corporate Action-Board approves Dividendbse
07 May, 07:27 pmThyrocare Technologies Limited has informed the Exchange that Board of Directors at its meeting held on May 07, 2026, recommended Final Dividend of Rs. 7 per equity share.nse
07 May, 07:24 pmAudited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026nse
07 May, 07:19 pmThyrocare Technologies Ltd - 539871 - Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended On March 31, 2026bse
07 May, 06:43 pmThyrocare Technologies Limited has informed the Exchange regarding Press release on Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026nse
07 May, 06:37 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
07 May, 06:24 pmThyrocare Technologies Limited has informed the Exchange about Investor Presentationnse
07 May, 06:19 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
07 May, 05:58 pmOutcome of Board Meeting held on May 07, 2026nse
07 May, 05:34 pmThyrocare Technologies Limited has informed the Exchange about cancellation of earning conference callnse
29 Apr, 01:50 pmThyrocare Technologies Ltd - 539871 - Corporate Action-Board to consider Dividendbse
29 Apr, 01:32 pmThyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026 And Recommendation Of The Final Dividend, If Any, For The Financial Year 2025-26.bse
25 Apr, 10:36 amThyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
01 Apr, 10:12 amThyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
29 Mar, 08:40 pmThyrocare Technologies Limited has informed the Exchange about Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015nse
24 Feb, 10:03 pmThyrocare Technologies Limited has informed the Exchange about additional capital infusion in Thyrocare Laboratories (Tanzania) Limited.nse
24 Feb, 09:57 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Acquisitionbse
02 Feb, 05:07 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
02 Feb, 05:04 pmThyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026nse
29 Jan, 12:15 pmPlease find attached the Copy of Newspaper Publication on Unaudited Financial results for the quarter and nine months ended on December 31, 2025nse
28 Jan, 08:26 pmThyrocare Technologies Limited has informed the Exchange about Link of Audio Recording for Investor Call held on January 28, 2026nse
28 Jan, 08:23 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
28 Jan, 04:38 pmThyrocare Technologies Limited has informed the Exchange about Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives.nse
28 Jan, 04:37 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015bse
28 Jan, 04:34 pmThyrocare Technologies Limited has informed the Exchange about Investor Presentationnse
28 Jan, 04:32 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
28 Jan, 04:27 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
28 Jan, 04:25 pmThyrocare Technologies Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "Press release on the unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025.".nse
28 Jan, 04:20 pmThyrocare Technologies Ltd - 539871 - Financial Results For The Quarter And Nine Months Ended December 31, 2025.bse
28 Jan, 04:14 pmThyrocare Technologies Limited has submitted to the Exchange, Outcome of the Board Meeting held on January 28, 2026, for the approval of financial results for the quarter and nine months ended December 31, 2025, and other matter as detailed in the enclosed letter.nse
27 Jan, 07:14 pmPress Release - Thyrocare Onboards Madhuri Dixit as the Brand Ambassador to Inspire Health and Well-being Across Indianse
22 Jan, 09:32 pmThyrocare Technologies Limited has informed the Exchange regarding 'Intimation of receipt of Awards'.nse
20 Jan, 04:22 pmThyrocare Technologies Limited has informed the Exchange that a conference call for the analysts/ investors is arranged by our management to discuss the Company's Unaudited Financial Results for the quarter and nine months ended December 31, 2025, on Wednesday, January 28, 2026, at 5:30 P.M (IST).nse
20 Jan, 03:21 pmThyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 31, 2025bse
17 Jan, 09:39 pmThyrocare Technologies Limited has informed the Exchange regarding Change of Name of M/s. M S K A & Associates, Statutory Auditor of the Company - upon Conversion of Firm into LLP.nse